These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23573226)

  • 41. Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide.
    Figura N; Palazzuoli A; Vaira D; Campagna M; Moretti E; Iacoponi F; Giordano N; Clemente S; Nuti R; Ponzetto A
    J Clin Pathol; 2014 Mar; 67(3):251-7. PubMed ID: 24334757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
    De Francesco V; Zullo A; Margiotta M; Marangi S; Burattini O; Berloco P; Russo F; Barone M; Di Leo A; Minenna MF; Stoppino V; Morini S; Panella C; Francavilla A; Ierardi E
    Aliment Pharmacol Ther; 2004 Feb; 19(4):407-14. PubMed ID: 14871280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of CagA status on serum gastrin and pepsinogen I and II concentrations in Japanese children with Helicobacter pylori infection.
    Fukuda Y; Isomoto H; Ohnita K; Omagari K; Mizuta Y; Murase K; Murata I; Moriuchi H; Kohno S
    J Int Med Res; 2003; 31(4):247-52. PubMed ID: 12964499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.
    van der Hulst RW; van der Ende A; Dekker FW; Ten Kate FJ; Weel JF; Keller JJ; Kruizinga SP; Dankert J; Tytgat GN
    Gastroenterology; 1997 Jul; 113(1):25-30. PubMed ID: 9207258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can bacterial virulence factors predict antibiotic resistant
    Brennan DE; Dowd C; O'Morain C; McNamara D; Smith SM
    World J Gastroenterol; 2018 Mar; 24(9):971-981. PubMed ID: 29531461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
    Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
    Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
    Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
    Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
    Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke.
    Diomedi M; Stanzione P; Sallustio F; Leone G; Renna A; Misaggi G; Fontana C; Pasqualetti P; Pietroiusti A
    Helicobacter; 2008 Dec; 13(6):525-31. PubMed ID: 19166418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura.
    Kodama M; Kitadai Y; Ito M; Kai H; Masuda H; Tanaka S; Yoshihara M; Fujimura K; Chayama K
    Helicobacter; 2007 Feb; 12(1):36-42. PubMed ID: 17241299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension.
    Ma WH; Wang XL; Du YM; Wang YB; Zhang Y; Wei DE; Guo LL; Bu PL
    BMC Cardiovasc Disord; 2012 May; 12():35. PubMed ID: 22642467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.
    Yong X; Tang B; Li BS; Xie R; Hu CJ; Luo G; Qin Y; Dong H; Yang SM
    Cell Commun Signal; 2015 Jul; 13():30. PubMed ID: 26160167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population.
    Iwanczak B; Laszewicz W; Iwanczak F; Dzierzanowska-Fangrat K; Rozynek M; Dzierzanowska D; Gosciniak G; Dlugosz J;
    J Physiol Pharmacol; 2014 Dec; 65(6):801-7. PubMed ID: 25554984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating interleukin-27 levels in Helicobacter pylori-infected patients with gastric or duodenal ulcers, independent of the bacterial cytotoxin-associated gene A virulence factor.
    Jafarzadeh A; Nemati M; Rezayati MT
    J Dig Dis; 2011 Aug; 12(4):302-7. PubMed ID: 21791025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relevance of underlying disease and bacterial vacA and cagA status on the efficacy of Helicobacter pylori eradication.
    Rudi J; Reuther S; Sieg A; Hoerner M; Stremmel W
    Digestion; 2002; 65(1):11-5. PubMed ID: 11961337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
    Maconi G; Russo A; Imbesi V; Cucino C; Bianchi Porro G
    Dig Liver Dis; 2000 May; 32(4):275-80. PubMed ID: 11515622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seminested polymerase chain reaction (PCR) for detecting Helicobacter pylori DNA in carotid atheromas.
    Arias E; Martinetto H; Schultz M; Ameriso S; Rivera S; Lossetti O; Sevlever G
    Diagn Mol Pathol; 2006 Sep; 15(3):174-9. PubMed ID: 16932074
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Liang H; Lin S; Ji Y; Xiao Y; Zheng G
    Ann Med; 2021 Dec; 53(1):1448-1454. PubMed ID: 34431440
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori.
    Murata-Kamiya N
    Microbes Infect; 2011 Sep; 13(10):799-807. PubMed ID: 21477660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.